{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:30:52Z","timestamp":1787031052082,"version":"build-2736575974"},"reference-count":114,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Delivery"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.4155\/tde.12.147","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T09:38:01Z","timestamp":1358933881000},"page":"239-250","source":"Crossref","is-referenced-by-count":27,"title":["Nanomedicine in Chemoradiation"],"prefix":"10.1080","volume":"4","author":[{"given":"Seth M","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology & Laboratory of Nano- & Translational Medicine University of North Carolina Chapel Hil\rNC\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Z","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology & Laboratory of Nano- & Translational Medicine University of North Carolina Chapel Hil\rNC\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20121"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr325"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710023371401"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02586980"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0714"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2009.05.004"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2006.02.007"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031317"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.16.1914"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7176"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106106"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032646"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0030"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr027"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00054-1"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-6-492"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90918-8"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053422"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.7812"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074943"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.139"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1998.tb00563.x"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(99)00248-5"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2012.45"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-chembioeng-061010-114300"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3064"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.8.4607"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.3.5.703"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.11.79"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh097"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmat2992"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.51"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604483"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-0576"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2007-0180"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0571-z"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07400.x"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802007700"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1444"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.14.3312"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.7.2445"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.157"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.08.003"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10201"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.08.044"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1634"},{"key":"e_1_3_2_3_49_1","first-page":"53","volume":"5","author":"Vishnu P","year":"2011","unstructured":"Vishnu P , RoyV. Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer. Breast Cancer (Auckl.)5, 53\u201365 (2011).","journal-title":"Breast Cancer (Auckl.)"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.937"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2011.07.005"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2011.23.2.59"},{"key":"e_1_3_2_3_53_1","unstructured":"Desai N . Nanoparticle albumin bound (nab) technology: a nanotechnology platform for biologically interactive drug delivery and targeting. Presented at: The 234th ACS National Meeting. Boston MA USA 19\u201323 August 2007."},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.09109"},{"issue":"17","key":"e_1_3_2_3_55_1","first-page":"5376","article-title":"Enhanced expression of SPARC\/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia\/acidity and with poor prognosis of patients.","volume":"63","author":"Koukourakis MI","year":"2003","unstructured":"Koukourakis MI , GiatromanolakiA, BrekkenRAet al. Enhanced expression of SPARC\/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia\/acidity and with poor prognosis of patients. Cancer Res. 63(17), 5376\u20135380 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-008-9135-x"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2534"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/la0502084"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100400"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711714105"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn203165z"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2011.07.067"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.05.016"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/10611860802088630"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2006.12.018"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.07.008"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.03.012"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S23211"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.08.053"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc800057g"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1021\/nl104117p"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.02.030"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(01)00275-9"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm374"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0655"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-011-9757-7"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9591-y"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-2574.2010.00249.x"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003651"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.e13104"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.708"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201000523"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn202797h"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000167902.53039.5a"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.11.3512"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600486"},{"issue":"2","key":"e_1_3_2_3_87_1","first-page":"473","article-title":"Pegulated liposomal doxorubicin and cisplatin given concurrently with conventional radiotherapy: a Phase I dose-escalation trial for patients with squamous cell carcinoma of head and neck and lung.","volume":"12","author":"Varveris H","year":"2004","unstructured":"Varveris H , KachrisS, MazonakisMet al. Pegulated liposomal doxorubicin and cisplatin given concurrently with conventional radiotherapy: a Phase I dose-escalation trial for patients with squamous cell carcinoma of head and neck and lung. Oncol. Rep. 12(2), 473\u2013481 (2004).","journal-title":"Oncol. Rep."},{"key":"e_1_3_2_3_88_1","first-page":"3625","article-title":"Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.","volume":"27","author":"Koukourakis MI","year":"2007","unstructured":"Koukourakis MI , PatlakasG, FroudarakisMEet al. Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma. Anticancer Res. 27(5B), 3625\u20133631 (2007).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_3_89_1","first-page":"1349","volume":"28","author":"Tsoutsou PG","year":"2008","unstructured":"Tsoutsou PG , FroudarakisME, BourosD, KoukourakisMI. Hypofractionated\/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC). Anticancer Res.28(2B), 1349\u20131354 (2008).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-006-1440-0"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000182440.11653.5f"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089161209800110"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.09.064"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1733"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016201732368"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s3061"},{"key":"e_1_3_2_3_97_1","first-page":"3785","article-title":"Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer.","volume":"22","author":"Karasawa K","year":"2002","unstructured":"Karasawa K , ShinodaH, KatsuiKet al. Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer. Anticancer Res. 22(6B), 3785\u20133788 (2002).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2003.11.017"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21003"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200052"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08956"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2008.0557"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2010.078"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/09553000050151637"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/50\/15\/N01"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/49\/18\/N03"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2011.04.067"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1120508109"},{"key":"e_1_3_2_4_2_1","unstructured":"Search for \u2018Abraxane\u2018 excluding \u2018Unknown status\u2018 on www.clinicaltrials.gov. http:\/\/clinicaltrials.gov\/ct2\/results?term=abraxane"},{"key":"e_1_3_2_4_3_1","unstructured":"ClinicalTrials database: NCT01300533. http:\/\/clinicaltrials.gov\/show\/NCT01300533"},{"key":"e_1_3_2_4_4_1","unstructured":"ClinicalTrials.gov www.clinicaltrials.gov"},{"key":"e_1_3_2_4_5_1","unstructured":"Search for \u2018Abraxane\u2018 and \u2018Concurrent\u2018 and \u2018Radiation\u2018 on www.clinicaltrials.gov. http:\/\/clinicaltrials.gov\/ct2\/results?term=abraxane+AND+concurrent+AND+radiation&Search=Search"},{"key":"e_1_3_2_4_6_1","unstructured":"ClinicalTrials database: NCT00689065. http:\/\/clinicaltrials.gov\/show\/NCT00689065"},{"key":"e_1_3_2_4_7_1","unstructured":"ClinicalTrials database: NCT01433068. http:\/\/clinicaltrials.gov\/show\/NCT01433068"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/tde.12.147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:32:03Z","timestamp":1715934723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/tde.12.147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.4155\/tde.12.147"],"URL":"https:\/\/doi.org\/10.4155\/tde.12.147","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}